XBIT - エックスバイオテック (XBiotech Inc.)

XBITのニュース

   XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall  2020/08/24 20:27:51 ABC News
Stocks that moved heavily or traded substantially Monday: XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall
   XBiotech Discovers COVID-19 Candidate Therapy  2020/08/17 12:20:00 GlobeNewswire
The Company has Identified Highly Targeted Anti-COVID-19 True Human Antibodies from Immune Donor Blood
   XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1⍺ Therapy  2020/07/22 13:20:00 GlobeNewswire
After Sale of its Previous Anti-IL-1a True Human Antibody, Company Now Has Production Cell to Manufacture New Molecule for Launch of Clinical Studies in 2021
   XBiotech antibody shows potential for treating stroke-related brain injury (NASDAQ:XBIT)  2020/07/14 14:32:18 Seeking Alpha
XBiotech (XBIT +2.6%) announces encouraging results from research conducted in Switzerland that supports the rationale of interleukin-1 alpha (IL-1⍺) block
   XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke  2020/07/14 13:25:00 GlobeNewswire
Antibody Therapy Targeting Interleukin-1a significantly reduced stroke related brain injury in animals and points to new potential blockbuster therapy
   XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall  2020/08/24 20:27:51 ABC News
Stocks that moved heavily or traded substantially Monday: XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall
   XBiotech Discovers COVID-19 Candidate Therapy  2020/08/17 12:20:00 GlobeNewswire
The Company has Identified Highly Targeted Anti-COVID-19 True Human Antibodies from Immune Donor Blood
   XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1⍺ Therapy  2020/07/22 13:20:00 GlobeNewswire
After Sale of its Previous Anti-IL-1a True Human Antibody, Company Now Has Production Cell to Manufacture New Molecule for Launch of Clinical Studies in 2021
   XBiotech antibody shows potential for treating stroke-related brain injury (NASDAQ:XBIT)  2020/07/14 14:32:18 Seeking Alpha
XBiotech (XBIT +2.6%) announces encouraging results from research conducted in Switzerland that supports the rationale of interleukin-1 alpha (IL-1⍺) block
   XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke  2020/07/14 13:25:00 GlobeNewswire
Antibody Therapy Targeting Interleukin-1a significantly reduced stroke related brain injury in animals and points to new potential blockbuster therapy
   XBiotech Discovers COVID-19 Candidate Therapy  2020/08/17 12:20:00 GlobeNewswire
The Company has Identified Highly Targeted Anti-COVID-19 True Human Antibodies from Immune Donor Blood
   XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1⍺ Therapy  2020/07/22 13:20:00 GlobeNewswire
After Sale of its Previous Anti-IL-1a True Human Antibody, Company Now Has Production Cell to Manufacture New Molecule for Launch of Clinical Studies in 2021
   XBiotech antibody shows potential for treating stroke-related brain injury (NASDAQ:XBIT)  2020/07/14 14:32:18 Seeking Alpha
XBiotech (XBIT +2.6%) announces encouraging results from research conducted in Switzerland that supports the rationale of interleukin-1 alpha (IL-1⍺) block
   XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke  2020/07/14 13:25:00 GlobeNewswire
Antibody Therapy Targeting Interleukin-1a significantly reduced stroke related brain injury in animals and points to new potential blockbuster therapy
   XBiotech Identifies “Super Bloods” for the Development of a True Human™ COVID-19 Therapy  2020/05/01 13:25:23 GlobeNewswire
Donors with Potent Natural Immunity Against the Virus are Identified as the Starting Point for XBiotech’s Drug Development Program to Treat COVID-19 …

calendar